Advertisement
Research Article

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

  • Motasim Badri mail,

    To whom correspondence should be addressed. E-mail: motasim.badri@hiv-research.org.za

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • Gary Maartens,

    Affiliation: Department of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa

    X
  • Sundhiya Mandalia,

    Affiliations: NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Medicine, Imperial College, Chelsea and Westminster Hospital, London, United Kingdom

    X
  • Linda-Gail Bekker,

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • John R Penrod,

    Affiliation: Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada

    X
  • Robert W Platt,

    Affiliation: Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

    X
  • Robin Wood equal contributor,

    equal contributor Contributed equally to this work with: Robin Wood, Eduard J Beck

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • Eduard J Beck equal contributor

    equal contributor Contributed equally to this work with: Robin Wood, Eduard J Beck

    Affiliations: NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

    X
  • Published: December 06, 2005
  • DOI: 10.1371/journal.pmed.0030004

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Is Antiretroviral Therapy Cost-Effective in South Africa?

R. Scott Braithwaite, Joel Tsevat
Perspective | published 31 Jan 2006 | PLOS Medicine
doi:10.1371/journal.pmed.0030060

HAART: A Cost-Effective Option for South Africa

Synopsis | published 6 Dec 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0030037